Loading…
[beta]-amyloid in lewy body disease is related to Alzheimer's disease-like atrophy
The aim of this study was to investigate whether amyloid deposition is associated with Alzheimer's disease (AD)-like cortical atrophy in Lewy body (LB) disease (LBD). Participants included 15 LBD with dementia patients (8 with dementia with Lewy bodies [DLB] and 7 with Parkinson's disease...
Saved in:
Published in: | Movement disorders 2013-02, Vol.28 (2), p.169 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 2 |
container_start_page | 169 |
container_title | Movement disorders |
container_volume | 28 |
creator | Shimada, Hitoshi Shinotoh, Hitoshi Hirano, Shigeki Miyoshi, Michie Sato, Koichi Tanaka, Noriko Ota, Tsuneyoshi Fukushi, Kiyoshi Irie, Toshiaki Ito, Hiroshi Higuchi, Makoto Kuwabara, Satoshi Suhara, Tetsuya |
description | The aim of this study was to investigate whether amyloid deposition is associated with Alzheimer's disease (AD)-like cortical atrophy in Lewy body (LB) disease (LBD). Participants included 15 LBD with dementia patients (8 with dementia with Lewy bodies [DLB] and 7 with Parkinson's disease [PD] with dementia [PDD]), 13 AD patients, and 17 healthy controls. Age, gender, and Mini-Mental State Examination scores were matched between patient groups. All subjects underwent PET scans with [11C]Pittsburgh Compound B to measure brain amyloid deposition as well as three-dimensional T1-weighted MRI. Gray-matter volumes (GMVs) were estimated by voxel-based morphometry. Volumes-of-interest analyses were also performed. Forty percent of the 15 DLB/PDD patients were amyloid positive, whereas all AD patients and none of the healthy controls were amyloid positive. Amyloid-positive DLB/PDD and AD patients showed very similar patterns of cortical atrophy in the parahippocampal area and lateral temporal and parietal cortices, with 95.2% of cortical atrophy distribution being overlapped. In contrast, amyloid-negative DLB/PDD patients had no significant cortical atrophy. Compared to healthy controls, parahippocampal GMVs were reduced by 26% in both the amyloid-positive DLB/PDD and AD groups and by 10% in the amyloid-negative DLB/PDD group. The results suggest that amyloid deposition is associated with AD-like atrophy in DLB/PDD patients. Early intervention against amyloid may prevent or delay AD-like atrophy in DLB/PDD patients with amyloid deposition. © 2012 Movement Disorder Society [PUBLICATION ABSTRACT] |
doi_str_mv | 10.1002/mds.25286 |
format | article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1317464282</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2920073161</sourcerecordid><originalsourceid>FETCH-proquest_journals_13174642823</originalsourceid><addsrcrecordid>eNqNyrFqQjEUgOEgLfRWO_QNDjg4xebkmmtWEaWzuEmRSE4xNtdoTkRun74Ounf6h_8T4h3VGJXSH63nsTbaNj1RoalRWm2mT6JS1hpZozUv4pX5oBSiwaYSq82OivuSru1iCh7CESJdO9gl34EPTI4JAkOm6Ap5KAlm8XdPoaU84oeQMfwQuJLTad8NxPO3i0xv9_bFcLlYzz_lKafzhbhsD-mSj7e1xRqnk2aira7_p_4AYc1E2A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1317464282</pqid></control><display><type>article</type><title>[beta]-amyloid in lewy body disease is related to Alzheimer's disease-like atrophy</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Shimada, Hitoshi ; Shinotoh, Hitoshi ; Hirano, Shigeki ; Miyoshi, Michie ; Sato, Koichi ; Tanaka, Noriko ; Ota, Tsuneyoshi ; Fukushi, Kiyoshi ; Irie, Toshiaki ; Ito, Hiroshi ; Higuchi, Makoto ; Kuwabara, Satoshi ; Suhara, Tetsuya</creator><creatorcontrib>Shimada, Hitoshi ; Shinotoh, Hitoshi ; Hirano, Shigeki ; Miyoshi, Michie ; Sato, Koichi ; Tanaka, Noriko ; Ota, Tsuneyoshi ; Fukushi, Kiyoshi ; Irie, Toshiaki ; Ito, Hiroshi ; Higuchi, Makoto ; Kuwabara, Satoshi ; Suhara, Tetsuya</creatorcontrib><description>The aim of this study was to investigate whether amyloid deposition is associated with Alzheimer's disease (AD)-like cortical atrophy in Lewy body (LB) disease (LBD). Participants included 15 LBD with dementia patients (8 with dementia with Lewy bodies [DLB] and 7 with Parkinson's disease [PD] with dementia [PDD]), 13 AD patients, and 17 healthy controls. Age, gender, and Mini-Mental State Examination scores were matched between patient groups. All subjects underwent PET scans with [11C]Pittsburgh Compound B to measure brain amyloid deposition as well as three-dimensional T1-weighted MRI. Gray-matter volumes (GMVs) were estimated by voxel-based morphometry. Volumes-of-interest analyses were also performed. Forty percent of the 15 DLB/PDD patients were amyloid positive, whereas all AD patients and none of the healthy controls were amyloid positive. Amyloid-positive DLB/PDD and AD patients showed very similar patterns of cortical atrophy in the parahippocampal area and lateral temporal and parietal cortices, with 95.2% of cortical atrophy distribution being overlapped. In contrast, amyloid-negative DLB/PDD patients had no significant cortical atrophy. Compared to healthy controls, parahippocampal GMVs were reduced by 26% in both the amyloid-positive DLB/PDD and AD groups and by 10% in the amyloid-negative DLB/PDD group. The results suggest that amyloid deposition is associated with AD-like atrophy in DLB/PDD patients. Early intervention against amyloid may prevent or delay AD-like atrophy in DLB/PDD patients with amyloid deposition. © 2012 Movement Disorder Society [PUBLICATION ABSTRACT]</description><identifier>ISSN: 0885-3185</identifier><identifier>EISSN: 1531-8257</identifier><identifier>DOI: 10.1002/mds.25286</identifier><identifier>CODEN: MOVDEA</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc</publisher><subject>Movement disorders</subject><ispartof>Movement disorders, 2013-02, Vol.28 (2), p.169</ispartof><rights>Copyright © 2012 Movement Disorders Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Shimada, Hitoshi</creatorcontrib><creatorcontrib>Shinotoh, Hitoshi</creatorcontrib><creatorcontrib>Hirano, Shigeki</creatorcontrib><creatorcontrib>Miyoshi, Michie</creatorcontrib><creatorcontrib>Sato, Koichi</creatorcontrib><creatorcontrib>Tanaka, Noriko</creatorcontrib><creatorcontrib>Ota, Tsuneyoshi</creatorcontrib><creatorcontrib>Fukushi, Kiyoshi</creatorcontrib><creatorcontrib>Irie, Toshiaki</creatorcontrib><creatorcontrib>Ito, Hiroshi</creatorcontrib><creatorcontrib>Higuchi, Makoto</creatorcontrib><creatorcontrib>Kuwabara, Satoshi</creatorcontrib><creatorcontrib>Suhara, Tetsuya</creatorcontrib><title>[beta]-amyloid in lewy body disease is related to Alzheimer's disease-like atrophy</title><title>Movement disorders</title><description>The aim of this study was to investigate whether amyloid deposition is associated with Alzheimer's disease (AD)-like cortical atrophy in Lewy body (LB) disease (LBD). Participants included 15 LBD with dementia patients (8 with dementia with Lewy bodies [DLB] and 7 with Parkinson's disease [PD] with dementia [PDD]), 13 AD patients, and 17 healthy controls. Age, gender, and Mini-Mental State Examination scores were matched between patient groups. All subjects underwent PET scans with [11C]Pittsburgh Compound B to measure brain amyloid deposition as well as three-dimensional T1-weighted MRI. Gray-matter volumes (GMVs) were estimated by voxel-based morphometry. Volumes-of-interest analyses were also performed. Forty percent of the 15 DLB/PDD patients were amyloid positive, whereas all AD patients and none of the healthy controls were amyloid positive. Amyloid-positive DLB/PDD and AD patients showed very similar patterns of cortical atrophy in the parahippocampal area and lateral temporal and parietal cortices, with 95.2% of cortical atrophy distribution being overlapped. In contrast, amyloid-negative DLB/PDD patients had no significant cortical atrophy. Compared to healthy controls, parahippocampal GMVs were reduced by 26% in both the amyloid-positive DLB/PDD and AD groups and by 10% in the amyloid-negative DLB/PDD group. The results suggest that amyloid deposition is associated with AD-like atrophy in DLB/PDD patients. Early intervention against amyloid may prevent or delay AD-like atrophy in DLB/PDD patients with amyloid deposition. © 2012 Movement Disorder Society [PUBLICATION ABSTRACT]</description><subject>Movement disorders</subject><issn>0885-3185</issn><issn>1531-8257</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqNyrFqQjEUgOEgLfRWO_QNDjg4xebkmmtWEaWzuEmRSE4xNtdoTkRun74Ounf6h_8T4h3VGJXSH63nsTbaNj1RoalRWm2mT6JS1hpZozUv4pX5oBSiwaYSq82OivuSru1iCh7CESJdO9gl34EPTI4JAkOm6Ap5KAlm8XdPoaU84oeQMfwQuJLTad8NxPO3i0xv9_bFcLlYzz_lKafzhbhsD-mSj7e1xRqnk2aira7_p_4AYc1E2A</recordid><startdate>20130201</startdate><enddate>20130201</enddate><creator>Shimada, Hitoshi</creator><creator>Shinotoh, Hitoshi</creator><creator>Hirano, Shigeki</creator><creator>Miyoshi, Michie</creator><creator>Sato, Koichi</creator><creator>Tanaka, Noriko</creator><creator>Ota, Tsuneyoshi</creator><creator>Fukushi, Kiyoshi</creator><creator>Irie, Toshiaki</creator><creator>Ito, Hiroshi</creator><creator>Higuchi, Makoto</creator><creator>Kuwabara, Satoshi</creator><creator>Suhara, Tetsuya</creator><general>Wiley Subscription Services, Inc</general><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20130201</creationdate><title>[beta]-amyloid in lewy body disease is related to Alzheimer's disease-like atrophy</title><author>Shimada, Hitoshi ; Shinotoh, Hitoshi ; Hirano, Shigeki ; Miyoshi, Michie ; Sato, Koichi ; Tanaka, Noriko ; Ota, Tsuneyoshi ; Fukushi, Kiyoshi ; Irie, Toshiaki ; Ito, Hiroshi ; Higuchi, Makoto ; Kuwabara, Satoshi ; Suhara, Tetsuya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_13174642823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Movement disorders</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shimada, Hitoshi</creatorcontrib><creatorcontrib>Shinotoh, Hitoshi</creatorcontrib><creatorcontrib>Hirano, Shigeki</creatorcontrib><creatorcontrib>Miyoshi, Michie</creatorcontrib><creatorcontrib>Sato, Koichi</creatorcontrib><creatorcontrib>Tanaka, Noriko</creatorcontrib><creatorcontrib>Ota, Tsuneyoshi</creatorcontrib><creatorcontrib>Fukushi, Kiyoshi</creatorcontrib><creatorcontrib>Irie, Toshiaki</creatorcontrib><creatorcontrib>Ito, Hiroshi</creatorcontrib><creatorcontrib>Higuchi, Makoto</creatorcontrib><creatorcontrib>Kuwabara, Satoshi</creatorcontrib><creatorcontrib>Suhara, Tetsuya</creatorcontrib><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Movement disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shimada, Hitoshi</au><au>Shinotoh, Hitoshi</au><au>Hirano, Shigeki</au><au>Miyoshi, Michie</au><au>Sato, Koichi</au><au>Tanaka, Noriko</au><au>Ota, Tsuneyoshi</au><au>Fukushi, Kiyoshi</au><au>Irie, Toshiaki</au><au>Ito, Hiroshi</au><au>Higuchi, Makoto</au><au>Kuwabara, Satoshi</au><au>Suhara, Tetsuya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>[beta]-amyloid in lewy body disease is related to Alzheimer's disease-like atrophy</atitle><jtitle>Movement disorders</jtitle><date>2013-02-01</date><risdate>2013</risdate><volume>28</volume><issue>2</issue><spage>169</spage><pages>169-</pages><issn>0885-3185</issn><eissn>1531-8257</eissn><coden>MOVDEA</coden><abstract>The aim of this study was to investigate whether amyloid deposition is associated with Alzheimer's disease (AD)-like cortical atrophy in Lewy body (LB) disease (LBD). Participants included 15 LBD with dementia patients (8 with dementia with Lewy bodies [DLB] and 7 with Parkinson's disease [PD] with dementia [PDD]), 13 AD patients, and 17 healthy controls. Age, gender, and Mini-Mental State Examination scores were matched between patient groups. All subjects underwent PET scans with [11C]Pittsburgh Compound B to measure brain amyloid deposition as well as three-dimensional T1-weighted MRI. Gray-matter volumes (GMVs) were estimated by voxel-based morphometry. Volumes-of-interest analyses were also performed. Forty percent of the 15 DLB/PDD patients were amyloid positive, whereas all AD patients and none of the healthy controls were amyloid positive. Amyloid-positive DLB/PDD and AD patients showed very similar patterns of cortical atrophy in the parahippocampal area and lateral temporal and parietal cortices, with 95.2% of cortical atrophy distribution being overlapped. In contrast, amyloid-negative DLB/PDD patients had no significant cortical atrophy. Compared to healthy controls, parahippocampal GMVs were reduced by 26% in both the amyloid-positive DLB/PDD and AD groups and by 10% in the amyloid-negative DLB/PDD group. The results suggest that amyloid deposition is associated with AD-like atrophy in DLB/PDD patients. Early intervention against amyloid may prevent or delay AD-like atrophy in DLB/PDD patients with amyloid deposition. © 2012 Movement Disorder Society [PUBLICATION ABSTRACT]</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/mds.25286</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0885-3185 |
ispartof | Movement disorders, 2013-02, Vol.28 (2), p.169 |
issn | 0885-3185 1531-8257 |
language | eng |
recordid | cdi_proquest_journals_1317464282 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Movement disorders |
title | [beta]-amyloid in lewy body disease is related to Alzheimer's disease-like atrophy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T13%3A18%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%5Bbeta%5D-amyloid%20in%20lewy%20body%20disease%20is%20related%20to%20Alzheimer's%20disease-like%20atrophy&rft.jtitle=Movement%20disorders&rft.au=Shimada,%20Hitoshi&rft.date=2013-02-01&rft.volume=28&rft.issue=2&rft.spage=169&rft.pages=169-&rft.issn=0885-3185&rft.eissn=1531-8257&rft.coden=MOVDEA&rft_id=info:doi/10.1002/mds.25286&rft_dat=%3Cproquest%3E2920073161%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_13174642823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1317464282&rft_id=info:pmid/&rfr_iscdi=true |